Illuminating new NPR feature traces the origins of #cancer immunotherapy back to its 19th century roots: n.pr/1SiItin
Value Of Innovation retweeted
Looking forward to ramping up @MLIWI work in 2016. Please join/follow if you back patient & doctor access & choice in care #mylifeisworthit
RX prices are rising, but still just 10% of total spending. Other services pose greater threat, says @TheHill op-ed: bit.ly/1P36JC2
Value Of Innovation retweeted
Replying to @theMMRF
@theMMRF - use My Life Is Worth It as a platform to advocate for patient access & choice in care #mylifeisworthit #myeloma #beatcancer
Pharma negotiates dramatic rebates with insurance co's on new medicines, yet patients still end up footing the bill: bit.ly/1NPo8PB
November was a banner month for multiple myeloma patients, with three promising new treatments approved by the FDA: wapo.st/1OGtFqJ
Extensive new @Forbes editorial by economist Wayne Winegarden on the dangerous impact drug price have on innovation: onforb.es/1N4ZCbG
Value Of Innovation retweeted
Replying to @VOInnovation
@VOInnovation: Former Dem congressman urges party not to vilify pharma & stifle innovation: bit.ly/1MW9pAG -More science, less fear
New study: Innovative blood #cancer therapies offer great patient value. So why do insurers refuse to cover them? bit.ly/1XMH3Bp
JUST IN: Former President Jimmy Carter reveals that his treatment has been successful and his #cancer is now gone: on-ajc.com/1R2Y71r
Former Democratic congressman urges party members not to vilify pharmaceutical industry & stifle medical innovation: bit.ly/1MW9pAG
#Cancer survivor on why proposed MA Rx price controls are dangerous to patients & disregard innovation's true value: bit.ly/1OFNmyV
Last weekend, inspirational multiple myeloma survivor Don Wright completed his 91st marathon since his diagnoses: kare11.tv/1IEdWUx
Value Of Innovation retweeted
@eRaceCancer @MLIWI @patientsrising - living with myeloma & other chronic disease is a marathon, not a sprint. Go Don! #mylifeisworhtit
Value Of Innovation retweeted
@eRaceCancer @patientsrising @MLIWI - we cannot wait for #100....
Why Dr. Bob Goldberg, co-founder of the Center for Medicine in the Public Interest, is thankful for big pharma: bit.ly/1MPXowF
New @acscan report finds in 6 states, key #cancer medications are in insurance co's highest co-payment tiers: n.pr/1XenxIo
.@latinodiabetes vice-chair on the short-sightedness of current complaints about high prices of new cholesterol meds bayareane.ws/21aKAbG
Recent @NEJM article highlights the limitations of so-called "value frameworks" designed to inform #cancer treatment bit.ly/1QWajQJ
Congress must make oral #cancer therapies more accessible by passing the Cancer Drug Coverage Parity Act of 2015: bit.ly/1SQIcky

